Robert Nelsen, Director, 10% Owner at FATE THERAPEUTICS INC (FATE), bought 2,207,936 shares at $6.00 ($5.8M) on 2013-10-04, disclosed to the SEC on 2013-10-07.
Open-market purchase of $5.8M FATE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,246,156 | $0 | 0.0% |
| 2 | $6.00 | 128,447 | $771K | 13.4% |
| 3 | $6.00 | 833,333 | $5.0M | 86.6% |
| Total | $2.61 avg | 2,207,936 | $5.8M | 100% |
| Filing → |
| SANA | BUY | 2024-02-12 | $8.0M | — | Filing → |
| NMRA | BUY | 2023-09-29 | $2.1M | — | Filing → |
| NMRA | BUY | 2023-09-27 | $1.0M | — | Filing → |